RMD - ResMed Inc. Stock Analysis

Stock Taper

SCREENER COMPARE ANY 2 STOCKS

RMD

RESMED INC.

NYSE

$229.19

▼ DOWN 0.73% (-1.68)

KEY STATISTICS

Market Cap$33.23 B

52w High$284.87

52w Low$180.27

Dividend Yield1.16%

FrequencyQuarterly

P/E21.28

Volume782.99K

Shares Out.145.06M

COMPANY

LEADERSHIP

CHIEF EXECUTIVE

Michael J. Farrell

COMPENSATION 2026

Salary$1,214,150

Stock Awards$8,775,059

Incentive Plan Pay$1,646,743

All Other Comp.$113,584

Total$14,674,543

ABOUT

SECTOR

Healthcare

WENT PUBLIC

June 2, 1995

METHOD OF GOING PUBLIC

N/A

FULL TIME EMPLOYEES

11,370

PRICE TARGET

Target High$300.00

Target Low$213.00

Target Median$230.00

Target Consensus$239.90

UPCOMING EARNINGS

DateOct 29, 2026

DayThursday

Rev. Est.$1.39B

OCT

THU

SPLIT RECORD

DATE	TYPE	RATIO
2010-08-31	Forward	2:1
2005-10-03	Forward	2:1
2000-04-03	Forward	2:1
1998-11-17	Forward	2:1

PRICE

$229.19 ▼ DOWN 0.73% (−$1.68)

OVERLAYS

About ResMed Inc.

https://www.resmed.com ↗

ResMed Inc. develops and markets medical devices and cloud-based software for respiratory and sleep disorders, offering solutions for hospitals, home care, and software management across approximately 140 countries.

INDUSTRY

Medical - Instruments & Supplies

A PRODUCT RESMED INC. IS KNOWN FOR

AirSense 11

ResMed's AirSense 11 is an advanced CPAP device with a touchscreen, heated humidifier, and digital connectivity via the myAir app to improve sleep apnea treatment and user adherence.

COMPETITORS

COMPETITOR

Revenue by Products

Icon	PRODUCT	Q1-2025	Q2-2025	Q1-2026	Q2-2026
	Sleep And Respiratory	$1.07B	$1.13B ▲	$1.17B ▲	$1.26B ▲
	Residential Care Software	$156.77M	$156.5M ▼	$166.14M ▲	$166.87M ▲

Revenue by Geography

REGION	Q1-2025	Q2-2025	Q1-2026	Q2-2026
Us Canada And Latin America	$707.31M	$748.95M ▲	$774.75M ▲	$835.03M ▲
Combined Europe Asia And Other Markets	$360.43M	$376.64M ▲	$394.69M ▲	$420.91M ▲
Global	$156.77M	$156.5M ▼	$166.14M ▲	$166.87M ▲